Oxis 9mcg Turbuhaler Clinical Experience Investigation
Study identifier:D5127L00001
ClinicalTrials.gov identifier:NCT01749462
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Oxis 9mcg Turbuhaler Clinical Experience Investigation
Medical condition
Chronic Obstructive Pulmonary Disease
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
398
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Feb 2013
Primary Completion Date: 01 Jul 2015
Study Completion Date: 01 Jul 2015
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Feb 2017 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Oxis | - |
Contacts
Investigators
Principal Investigator
Shigeru Yoshida
Astrazeneca KK
